title: Prompt response to high-dose intravenous immunoglobulins given as first-line therapy in post-transplant thrombotic thrombocytopenic purpura.
authors.forename: E P
authors.initials: EP
authors.lastname: Alessandrino
authors.forename: G
authors.initials: G
authors.lastname: Martinelli
authors.forename: A
authors.initials: A
authors.lastname: Canevari
authors.forename: P
authors.initials: P
authors.lastname: Bernasconi
authors.forename: D
authors.initials: D
authors.lastname: Caldera
authors.forename: A
authors.initials: A
authors.lastname: Colombo
authors.forename: C
authors.initials: C
authors.lastname: Bernasconi
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D010956:Plasmapheresis; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000209:etiology* / Q000628:therapy*
chemical_list: D016756:Immunoglobulins, Intravenous